chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash non injection site arm; bumps non injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (bumps non injection site arm) and RASH (rash non injection site arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for an unknown indication.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced LYMPHADENOPATHY (bumps non injection site arm). On 05-Mar-2021, the patient experienced RASH (rash non injection site arm). At the time of the report, LYMPHADENOPATHY (bumps non injection site arm) and RASH (rash non injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE LYMPHADENOPATHY (bumps non injection site arm) and RASH (rash non injection site arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for an unknown indication.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 04-Mar-2021, the patient experienced INJECTION SITE LYMPHADENOPATHY (bumps non injection site arm). On 05-Mar-2021, the patient experienced RASH (rash non injection site arm). At the time of the report, INJECTION SITE LYMPHADENOPATHY (bumps non injection site arm) and RASH (rash non injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Consumer denied for further follow-up, she is doing good.
Started with chills, followed by headache, nasseau, vomiting, fatigue, muscle aches and insomnia.  The chills receded by 11:00.  I vomited at 5:30 AM and could sleep.  The other symptoms lasted until 1/15 during  the night.  Was fatigued and ill feeling through 1/16.  On 1/17 I woke up feeling much better and was able to resume normal  activities.  Very minimal pain in left arm (site of injection).
no pain but arm noted to have large 4 in x 2 in raised (indurated) red mark; became tender p/initial 24 hrs;
Information has been received from a physician concerning a male patient who on 09-AUG-2010 was inadvertently vaccinated with a dose of VARIVAX (Merck) (Lot number unknown) instead of the intended ZOSTAVAX (Merck) due to human error. No adverse effect was reported. No further information is available.
CHILD NOTICED SMALL RED BUMPS EARLIER BY 10P MOM STATES CHILD COVERED IN HIVES.  MOM CONTACTED PCP AND WAS TOLD TO GIVE CHILD HER ALLERGY MEDICINE, BY MORNING HIVES WERE GONE.
Received 0.5mL for booster (4th) dose instead of 0.25 mL
Received imm on 8/18/10; returned for PPD reading. Baby looked lethargic and warm - hot to touch. Suggested evaluation by pediatrician. 4 oz weight loss T 104.6 rectal. Advised to go to ER for observation (office was closed). Parents wished to give proper dose of Acetaminophen to see if T decreased down. Fever responded to acetaminophen but needed Q4 hours X 2 days. Child also teething.
Guillan Barre Syndrome. Hospitalized. IVIG 5 day treatment. 5 day treatment Plasma Ferisis transfusions.  Numb Feet- Leg Paralysis- Numb Hands
Rapid heartbeat. Extremely high blood pressure. Numbness in left arm, fingers, head, left side face. Headache. Pain in upper chest area, left and right. Ringing in left ear. Hearing loss left ear. Paramedics called, monitored condition, released
1050 am c/o of thickness in throat, denied SOB and cough - T97.1, ZYRTEC 5mg PO liquid administered 1110am continues to c/o slight tickle in throat, ZYRTEC 5mg PO liquid administered (second dose) 1120am reported that she felt also fever, no SOB and cough reported.
Did not receive their second vaccination; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Did not receive their second vaccination) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Did not receive their second vaccination) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Did not receive their second vaccination) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medications were provided. Patient would like to know if they can receive the second vaccination at the time of report. No treatment medications were reported.   Reporter did not allow further contact
The vial was punctured for more than 12 hours, doses were administered after the 12 hours; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was punctured for more than 12 hours, doses were administered after the 12 hours) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046821A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included TRAZODONE for an unknown indication.    On 03-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was punctured for more than 12 hours, doses were administered after the 12 hours). On 03-Oct-2021, EXPIRED PRODUCT ADMINISTERED (The vial was punctured for more than 12 hours, doses were administered after the 12 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication were reported. No concomitant medication were reported. HCP  reported that a nurse gave 4 patients expired Moderna COVID-19 vaccines. The vial was punctured for more than 12 hours, doses were administered after the 12 hours.
Patient came into the pharmacy today (5/14/22) showing his right arm with 2 large size bruises. One was located right where the injection would have occurred and the other was further down his arm, about 3-4 inches up from his wrist. He said they started a few days ago and was wondering if was from the vaccine booster. He also stated he had felt itchy. He claims not to have fallen, nor have any other symptoms but wanted to know if this was normal. I stated it's typically more common for a reaction to occur closer to the date the vaccine was administered, not 3-4 days later, but that I would report it to VAERS. He said he would monitor it and possibly stop at an urgent care for a complete work-up if he continued to feel apprehensive about it.
Case number PHEH2015US026844, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 27 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501, expiry date: May 2016) into left deltoid on 05 Oct 2015. It was reported that FLUVIRIN administered had a temperature excursion of 34 degrees Fahrenheit overnight. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
Induration, redness and warm to touch 5 X 6cm on both thighs.
Started low grade fever, aches, pains, joint pain, chills, cold sweats.  This lasted 1 - 2 days.  Low grade fever continued for 5 days.  General malaise continued 2 days longer.  On the 8 day, I developed a itchy rash that has lasted intermittently 5 days now, muscle aches, joint pain returned (with a vengence) along with generalized swelling, especially in the hands and feet, and fever.  So much discomfort that I am unable to perform ADLs with efficiency.  On day 11 I went to my family doctor who gave me a shot of Toradol for the swelling and discomfort, advised me to take OTC ibuprofen, and prescribed and antibiotic (Keflex TID), even though he believes this is a viral sickness.  This brings us to a total of 13 days of reaction / sickness at this point in time.
8/11/04 Client developed large reddened area (approximately 6cm)with a lump on the left upper outer arm. Area developed approximately 24-30 hrs after injection of DTaP. Grandparent gave child benedryl. Advised parent to apply cool packs and sent her to her physician for further evaluation.  8/16/04 Spoke with parent again no further problems with left arm. Reddness and lump are gone. Nothing done besides cool packs and tylenol for discomfort.
has a cold; does not feel good; caller was weak from the first shot; it hurt when caller coughed; nasal congestion; it hurt when caller coughed; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (BNT162B2), (Formulation: Solution for injection, Batch/Lot Number: Unknown; Expiration Date: Unknown) dose 1, single via an unspecified route of administration on an unspecified date for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  On an unspecified date the patient  stated that he has a cold, and today is the day for his second vaccine. Patient does not feel good and yesterday was worse. Today is a little bit better. He was wondering about receiving his second dose. Patient stated that he was just going to push back the date, as it was supposed to be today at 11:15 and he can see now that nobody was going to answer his question so he was just going to make his appointment for next day. Patient adds hopefully he felt a little bit better next day. Patient adds that the second day of the shot, he was pretty weak from the first shot. He has a cold now. He was coughing pretty bad and it hurt when he coughed. He was coughing very little. He felt a little bit better but now he was feeling weaker. Patient states if he gets the shot  and the second day was worse than the first shot, cold could get worse or it will hurt him anyway. Patient asked can he just reschedule his appointment for next day. Patient states again that he is not going to find that information out so he just wants to go ahead and reschedule for next day. The patient was pushing back the date of his second vaccination. Patient declined to file safety report and states he just wants to make an appointment for next day. The outcome of all event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt. presents to ER on 09/28/2021 with temp of 101.5. Pt. reports that he had fallen out of bed and is uncertain as to why he had fallen out of bed, but thought that he was trying to get self to BR. Pt. reports that he was not able to get up off the floor and normally ambulates ad lib. At home pt. is dependent on O2 at 4L per cannula. Pt. when found by EMS was noted to have O2 sat. in the 60%. (Unsure if oxygenation was on RA or on O2). Pt. c/o non-productive cough. Pt. received his third covid vaccination, (booster) on 09/07/2021. Pt. in ER denied SOB, CP, HA, rash, abd. pain, diarrhea, constipation, dysuria, or confusion.
He reports minimal tenderness in arm, but the day after fever 101.0, shaky, nausea, no rash, no difficulty breathing, body aches, sweats, dizziness, denies sick contacts, lasted 8-10hours. Thinks related to the vaccination. Reports that he had similar type of reaction with mmr in the past.  He did not seek treatment
patient developed seizures after the vaccine; Crying abnormally; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A 4-month-old male patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), on 07Mar2023 as dose 1, single (Lot number: FP2144, Expiration Date: 30Sep2024) at the age of 4 months intramuscular, in left thigh for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CRYING (non-serious) with onset 08Mar2023, outcome "recovered" (10Mar2023), described as "Crying abnormally"; SEIZURE (hospitalization, medically significant) with onset 11Mar2023, outcome "unknown", described as "patient developed seizures after the vaccine". The patient was hospitalized for seizure (start date: 13Mar2023, discharge date: 17Mar2023, hospitalization duration: 5 day(s)). The event "patient developed seizures after the vaccine" required emergency room visit. The patient underwent the following laboratory tests and procedures: lab work: Unknown results, notes: the patient had lab work; Magnetic resonance imaging: Unknown results, notes: the patient had multiple MRI's while he was hospitalized. Therapeutic measures were taken as a result of seizure. Caller states that the patient developed seizures after the vaccine. The patient had no fever. The mom reported that the patient was crying abnormally on 08Mar2023 until 10Mar2023. The seizures started for the patient on 11Mar2023. The patient had 3-4 seizures on the 11th. Then the patient had 4 seizures that Sunday, 6 that Monday. The patient was taken to the Emergency Room that Monday and was admitted to the hospital on 13Mar2023. The patient was discharged from the hospital on 17Mar2023. Caller states that sometime during the patient's hospitalization for the seizures, the patient was started on Keppra, 100mg/mL, 2mL by mouth twice a day. Caller does not know the date that the patient was started on the Keppra but states that it was after the seizures that started on 11Mar2023, the patient was started on Keppra somewhere between 13Mar2023 and 17Mar2023 when the patient was in the hospital.; Sender's Comments: There is a reasonable possibility that the events crying and seizure were related to PREVNAR 13 based on known drug safety profile and temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
I had multiple small blood clots in right leg, saw doctor and he didn't think I need to see vein specialist, first booster did create blood clots that were discovered through ultrasound, the May vaccine bigger blood clots were discovered originally size of pea next were marble size.
Tight throat/ abd pain 97.7 temp 3.5 hours later - 50mg benadryl given  felt worse pt went to UC elsewhere , gave 0.3 epi before leaving. AMA signed
I am experiencing blood in my urine. After the first covid shot, I noticed my urine was slightly pink and this cleared after one day. After this second shot, the blood is more prevalent and my urine is darker.  I do not have any other signs of a UTI. I had a fever yesterday but nothing today. There is no pain when I urinate. I do not have a history of UTI's at all.
gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021; gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) and PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) and PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021). On 06-Oct-2021, EXPIRED PRODUCT ADMINISTERED (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) and PRODUCT STORAGE ERROR (gave 11 patients Moderna Covid-19 Vaccine doses  on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment medications were not provided.
Approx 2 hrs after injection, pt c/o itching of neck, arms, back & chest. Also, c/o "tingling" sensation of lips. Epi-Pen given w/relief. Called 911, transported to ER & observed. Discharged with Epi-Pen & Tagamet Rx.
Information has been received from a physician concerning an approximately 20 year old female who, on an unspecified date was vaccinated in the deltoid with her first dose of Gardasil (lot # not reported). The patient felt faint after receiving the first vaccination. On an unspecified date, the patient was vaccinated in the deltoid with her second dose of Gardasil (lot # not reported). On approximately 25-Feb-2008, also reported as "within the last 3 weeks", the patient felt both her hands and feet were numb after receiving the second dose of Gardasil. The reporter noted that the adverse event improved "on therapy" (not otherwise specified) and that the patient was recovering. The patient sought unspecified medical attention. No additional information was provided. Additional information has been requested. This is in follow-up to report (s) previously submitted on 1/14/2008. Initial and follow up information has been received forma physician and a licensed practical nurse concerning 24 year old female (142 lb; 64 inches) who, on an unspecified date was vaccinated in the deltoid with her first dose of GARDASIL (lot # not reported). The patient felt faint after receiving the first vaccination. On 28-FEB-2008, the patient was vaccinated in the right deltoid with her second dose (also reported as her third dose) of GARDASIL vaccine (Lot # 660387/1967U). On 28-FEB-2008, the patient felt became light headed and then complained of numbness in arms and legs. Her hands and arms were stiffening up. The patient was crying due to the symptoms. The patient was hyperventilating. After 20 minutes, the patient relaxed and the symptoms disappeared. Additional information is not expected.
No additional AE; multiple temperature excursions/multiple doses of ROTATEQ were administered to multiple patients; This spontaneous report was received from an office administrator referring to an infant female patient of unknown age. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.      On 08-NOV-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # 1661000, expiration date 13-MAY-2021, at a dose of 2 milliliter once, orally for prophylaxis. There were multiple temperature excursions (temperature values and time frames were not reported) recorded by a data logger.  No addtional adverse event reported.  This is one of several reports received from the same reporter.
Approximately 2 weeks after the first dose of Pfizer, I began having chest pain, blood pressure spikes, headaches, and increased heart rate. I have historically had a history of low pressure and have no comorbidities related to hypertension. I am an active, healthy 57-year old with an excellent BMI of approximately 21 (5'9" and 143 lbs). The symptoms above tended to happen in the afternoon and evening. I had absolutely no fear of the COVID-19 vaccine or injections in general. I am a firm believer in vaccines, and I was actually looking forward to receiving the vaccine to protect against COVID-19. I did not related the symptoms to the vaccine, so I did not seek medical attention at this time. See continuation below. The blood pressure spikes were in the range of stage 1 and 2 hypertension. I assumed the symptoms were related to anxiety, so I used Ativan as needed in an attempt to reduce the symptoms. These symptoms persisted and got worse after the second dose of Pfizer and eventually led to an emergency room visit, so I decided to file this report. I have filed an additional report for the second dose to detail the worsening of symptoms.
Itchy mouth, felt like having a hard time breathing, treated with Benadryl, Also fever and tired lasted 24 - 36 hours.
Within 5 minutes of receiving shot I felt woozy, had mild face and throat swelling, blurry vision, and hives on face. All symptoms except woozy feeling went away within 3 hours. Did not feel fully well until 24 hours later.
Chills, body aches, fatigue, dizzyness, febrile state, malaise, tightness at injection site and pain at touch
Daily bleeding not heavy but enough to have to wear a pad. Have had  three  half dollar size clots there has been no let up on the bleeding .
with history of 3 normal, healthy term pregnancies and births with no complications as well as 1 SAB at 10 weeks with pregnancy #2.  Only risk factor is BMI of 61. EDD 03/25/2023.  Patient received the Moderna Bivalent on Friday and felt "unwell" with typical vaccine symptoms that afternoon. She felt better on Saturday and reported a busy day. Saturday evening she felt that baby was moving less than usual but thought she just wasn't noticing the movement due to position change. By Monday morning, she contacted me as her care provider and when I assessed, I could not find so we went immediately to the hospital and was confirmed by ultrasound. Baby was born by cesarean at 38.2 weeks and a thrombus was noted at the base of the cord as well as several small clots on the placenta. Based on baby's appearance, it was estimated baby had died about 48 hours before birth, sometimes on Saturday.
I passed out on Monday May 3.  I continued to have symptoms like chronic fatigue, trouble focusing, dizziness, sinus pressure, and I had trouble walking by myself.  These symptoms continued on and off for approximately 9 weeks.  I also had blood pressure fluctuations on May 12 where my blood pressure increased for a period of about 2 hours.  My normal blood pressure is around 116/71.  It had increased to 173/81 during the fluctuations.  It took a long time for the feeling of not being able to focus and the fatigue to go away.  I spent many weeks in the bed.